PectaSol supplement health benefit

PectaSol is a new form of modified citrus pectin distributed by EcoNugenics, Santa Rosa, CA.

Modified Citrus Pectin Powder with PectaSol

Pectin, a soluble dietary fiber naturally present in citrus fruit, cannot be absorbed by the human digestive tract. However, pectin can be pH modified to shorten the molecular chain. This process creates smaller polysaccharide fragments that are easily absorbed and utilized by the body. Source Naturals Modified Citrus Pectin with Pectasol is made up of very short chains of molecules, containing fragments of the same molecular weight used in recent scientific studies. Some of the constituents of Modified Citrus Pectin that are believed to be responsible for its beneficial properties are the galactosyl fractions. Pectasol ingredients come from the white pith of oranges, grapefruit and lemons.

Modified Citrus Pectin 5 g

Pectasol for lead toxicity
The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels.
Altern Ther Health Med. 2008 Jul-Aug; Department of Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Republic of China.
This clinical study was performed to determine if the oral administration of modified citrus pectin (MCP) is effective at lowering lead toxicity in the blood of children between the ages of 5 and 12 years. Hospitalized children with a blood serum level greater than 20 microg/dL, were given 15 g of MCP ( PectaSol ) in 3 divided dosages a day. Blood serum and 24-hour urine excretion collection GFAAS analysis were performed on day 0, day 14, day 21, and day 28. This study showed a dramatic decrease in blood serum levels of lead and a dramatic increase in 24-hour urine collection. The need for a gentle, safe heavy metal-chelating agent, especially for children with high environmental chronic exposure, is great. The dramatic results and no observed adverse effects in this pilot study along with previous reports of the safe and effective use of PectaSol in adults indicate that PectaSol could be such an agent.

Pectasol and cancer
Research with modified citrus pectin has shown it to be effective in slowing the progression, metastasis and angiogenesis of several types of cancer. The first human study described below was done with patients with late stage, breast, prostate, colorectal, kidney, pleural or lung, cervix/uterine cancer, liver, pharynx, pancreatic, stomach, melanoma and bile duct cancers. This clinical trial was published in the peer-reviewed journal Clinical Medicine: Oncology, where it showed a significant improvement of quality of life and stabilization of disease for patients with advanced solid tumors. Modified citrus pectin, a natural substance modified from the peel of citrus fruit has been used in integrative cancer therapy to help keep aberrant cells from clustering and blocking the formation of blood vessel attachment. The absorption into the blood stream is based on the size and weight of its molecules. Modified citrus pectin molecules bind to receptors on cancerous cells, preventing these cells from attaching to healthy tissue and blocking the formation of blood vessels to feed the cancerous cells. Once this has occurred, the cancer cells starve and die or are eliminated by the immune system. Pectasol is a form of modified citrus pectin that goes through an enzymatic process that reduces the pectin’s molecular size.

Treatment and Scientific Data of Study:
The treatment in the advanced tumor and previous studies consisted of the oral intake of five grams of Modified citrus pectin three times a day. One cycle of therapy was defined as four weeks of treatment. Forty-nine patients (between 36 and 82 years old) with various advanced solid tumors were enrolled. Twenty-nine patients were evaluated for clinical benefit after two cycles of treatment. All patients tolerated the therapy well without any adverse effects. The results also demonstrated that after two cycles of oral intake of PectaSol-C, 6/29, (20%) had an overall clinical benefit with a stabilization or improvement of life quality. On intent to treat basis 11/49 patients (22%) showed a stable disease after two cycles and 12% had a SD for more than 24 weeks. One patient with advanced and hormonal resistant prostate cancer had a 50% decrease in PSA with significant improvement in his quality of life. Most of the patients had improvements in their life quality as reflected in the Karnofsky scores. The Modified citrus pectin used in the advanced tumor study is commercially available in the US. It's called PectaSol-C and distributed by EcoNugenics, Santa Rosa, CA.

Passion Rx home